Table of Contents
Volume 4 | Issue 5
Publication Date: March 2003- Abstract
- No Access
- Pay-Per View
- Full Text
- Add to Cart
Editorial | ||
266 |
Antisense Oligonucleotides in Lung Cancer: Do They Really Make Sense? Chandra P. Belani |
|
Researches in Brief | ||
269-272 |
Molecularly Targeted Chemoprevention of Lung Cancer Angelia D. Gibson, Chandra P. Belani, Mark Socinski |
|
273-276 |
Cyclooxygenase-2: A Target for Chemoprevention and Treatment of Non–Small-Cell Lung Cancer Angelia D. Gibson, Chandra P. Belani |
|
277-278 |
Spiral Computed Tomography Screening for the Diagnosis of Early-Stage Lung Cancer Heather DeGrendele, Chandra P. Belani, Mark Socinski |
|
Comprehensive Review | ||
279-287 |
Emerging Role of Topotecan in First-Line Therapy of Small-Cell Lung Cancer F. Anthony Greco, John D. Hainsworth |
|
Original Contributions | ||
288-293 |
Docetaxel Versus Docetaxel/Cisplatin in Patients with Advanced Non–Small-Cell Lung Cancer: Preliminary Analysis of a Multicenter, Randomized Phase III Study V. Georgoulias, A.G. Pallis, C. Kourousis, A. Alexopoulos, A. Ardavanis, A. Agelidou, M. Agelidou, M. Toumbis, S. Tzannes, G. Pavlakou, P. Ziotopoulos, E. Tzelepatiotis, N. Samaras |
|
294-297 |
A Multicenter Phase II Study of Gemcitabine and Oxaliplatin for Malignant Pleural Mesothelioma Wolfgang Schuette, Thomas Blankenburg, Kathrin Lauerwald, Jens Schreiber, Ines Bork, Bettina Wollschlaeger, Dorothea Treutler, Claus-Peter Schneider, Reiner Bonnet |
|
298-302 |
p53 and Bcl-2 Protein Expression and Its Relationship with Prognosis in Small-Cell Lung Cancer Manuela Zereu, Jeferson Jose Fonseca Vinholes, Cláudio Galeano Zettler |
|
Commentary | ||
303 |
p53 and Bcl-2 in Small-Cell Lung Cancer Ravi Salgia, Arthur T. Skarin |
|
Clinical Commentary | ||
304-306 |
Induction Therapy for Early-Stage Lung Cancer? The Rationale Behind the Question Eric Vallières |
|
Translational Medicine | ||
307-313 |
Bcl-2 as a Target for Overcoming Chemoresistance in Small-Cell Lung Cancer Dean A. Fennell |
|